1. Home
  2. KRYS vs AHL Comparison

KRYS vs AHL Comparison

Compare KRYS & AHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • AHL
  • Stock Information
  • Founded
  • KRYS 2015
  • AHL 2002
  • Country
  • KRYS United States
  • AHL Bermuda
  • Employees
  • KRYS N/A
  • AHL N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • AHL Property-Casualty Insurers
  • Sector
  • KRYS Health Care
  • AHL Finance
  • Exchange
  • KRYS Nasdaq
  • AHL Nasdaq
  • Market Cap
  • KRYS 3.8B
  • AHL 3.2B
  • IPO Year
  • KRYS 2017
  • AHL 2025
  • Fundamental
  • Price
  • KRYS $143.08
  • AHL $30.34
  • Analyst Decision
  • KRYS Strong Buy
  • AHL Strong Buy
  • Analyst Count
  • KRYS 9
  • AHL 7
  • Target Price
  • KRYS $208.78
  • AHL $41.14
  • AVG Volume (30 Days)
  • KRYS 374.0K
  • AHL 230.4K
  • Earning Date
  • KRYS 08-04-2025
  • AHL 01-01-0001
  • Dividend Yield
  • KRYS N/A
  • AHL N/A
  • EPS Growth
  • KRYS 109.01
  • AHL N/A
  • EPS
  • KRYS 4.16
  • AHL 5.84
  • Revenue
  • KRYS $333,448,000.00
  • AHL $3,195,000,000.00
  • Revenue This Year
  • KRYS $44.05
  • AHL N/A
  • Revenue Next Year
  • KRYS $46.15
  • AHL $8.26
  • P/E Ratio
  • KRYS $34.43
  • AHL $5.19
  • Revenue Growth
  • KRYS 247.53
  • AHL 9.09
  • 52 Week Low
  • KRYS $122.80
  • AHL $28.85
  • 52 Week High
  • KRYS $219.34
  • AHL $36.10
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 57.50
  • AHL N/A
  • Support Level
  • KRYS $135.86
  • AHL N/A
  • Resistance Level
  • KRYS $143.44
  • AHL N/A
  • Average True Range (ATR)
  • KRYS 5.15
  • AHL 0.00
  • MACD
  • KRYS 1.07
  • AHL 0.00
  • Stochastic Oscillator
  • KRYS 80.33
  • AHL 0.00

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About AHL Aspen Insurance Holdings Limited Class A Ordinary Shares

Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.

Share on Social Networks: